Loading stock…

Central Garden & Pet Company (CENT) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Central Garden & Pet Company

CENTMarket cap $2.24BPrice $40.1

Country🇺🇸United States

SectorConsumer

IndustryHousehold

Makes and distributes pet supplies and lawn & garden products, from dog treats to grass seed, across thousands of retailers nationwide. Its two-segment split lets it profit whether Americans are gardening or pampering pets.

In Bastion Portfolios?

52W Return+31%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-2%2

Revenue Forecast

Rev CAGR (1y)-4%2

Rev CAGR (3y)+1%1

Rev CAGR (5y)+2%2

Earnings Forecast

EPS Growth Y+1+29%8

EPS Growth Y+2+1%4

EPS Growth Y+3+2%4

Quality

Margins

EBIT Margin8%4

Net Income Margin5%4

Free Cash Flow Margin11%6

Debt

Net Debt/EBITDA0.96

Efficiency

ROE10%5

ROA4%6

Earnings Stability55

GEAR+AVERAGE44

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)128

P/E Ratio (Forward 3y)126

P/BV1.39

EV Multiples

EV/EBITDA Fwd78

EV/EBIT Fwd108

Yield

Free Cash Flow Yield15.5%10

Dividend Yieldna–

Momentum

Short term

1 month return-2%7

3 month return-5%5

YTD return+25%8

Mid term

Price vs 52wHigh85%7

1 year return+32%8

Long term

3 year return+18%4

5 year return+4%4

Risk Shield

Price Risk

Beta0.48

Volatility26%8

Free Cash Flow

Free Cash Flow Margin11%6

Free Cash Flow Yield15.5%10

Quality

ROCE8%5

Earnings Stability55

Net Debt/EBITDA0.96

02Growth

Is it actually growing, and how fast?

CENTCentral Garden & Pet

Revenue FY25$3.1B

GROWTH RATING↗

VERY WEAK6 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-4%2

Revenue, next 3Y, CAGR+1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+29%8

EPS growth, FY27E+1%4

EPS growth, FY28E+2%4

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue fell 2%/yr over the last 3 years and is set to grow around 0.8%/yr from here.

Earnings are set to grow in step with sales (EPS about 2%/yr vs revenue 0.8%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 94% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to grow 0.8%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-5%5

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high85%7

1-year return+32%8

3-year return+18%4

5-year return+4%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 32% over the past year, but 15% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+18% over three years and +4.5% over five), roughly average for the market.

Returns sit at the market level over three months (-5%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Central Garden & Pet Company. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CENTCentral Garden & Pet

Revenue FY25$3.1B

GROWTH RATING↗

VERY WEAK6 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-2%2

Revenue, next 1Y-4%2

Revenue, next 3Y, CAGR+1%1

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+29%8

EPS growth, FY27E+1%4

EPS growth, FY28E+2%4

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue fell 2%/yr over the last 3 years and is set to grow around 0.8%/yr from here.

Earnings are set to grow in step with sales (EPS about 2%/yr vs revenue 0.8%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 94% of companies worldwide.

Revenue fell 2%/yr over the last 3 years, behind 80% of companies worldwide.2/10

Revenue is set to grow 0.8%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-5%5

YTD return+25%8

MID & LONG-TERM▾SCORE

% of 52-week high85%7

1-year return+32%8

3-year return+18%4

5-year return+4%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 32% over the past year, but 15% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and so far this year (+25%).

WATCH

Average long-term results. Multi-year returns are middling (+18% over three years and +4.5% over five), roughly average for the market.

Returns sit at the market level over three months (-5%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Central Garden & Pet Company. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community